Frédéric Frézard has been a professor at the Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil, since 1997. A member of the Brazilian Local Chapter Controlled Release Society, he earned a Ph.D. (1990) in Biophysics from the Université Paris 6, France. His expertise includes membrane biophysics, drug delivery systems and antimicrobials. From 1987 to 1991, his main research interest was transport mechanisms involved in cellular drug resistance. From 1992 until now, he has developed several innovative lipid-based delivery strategies for drugs and bioactive peptides, seeking therapeutics and vaccines against the neglected disease leishmaniasis. As of 2000, he has also made significant contributions to the pharmacology of antimonial drugs and the improvement of their delivery through chemical and nanotechnology approaches. In addition to authoring more than 140 peer-reviewed publications, he invented a liposome-based cosmeceutical formulation that reached the Brazilian market in 2018.